Importantly, it has been known since the 1980s that MYCN amplification is directly associated with low major histocompatibility complex expression [12], and it has been confirmed more recently that MYCN‐amplified neuroblastomas have one of the most immune cell excluded TMEs of all human cancer [13]. The gene discussed is MYCN; the disease is neuroblastoma.